drugset / Trial / NCT00548678

Platelet Function and Safety After IV and Oral Diclofenac, IV Ketorolac and Oral Aspirin in Adult Volunteers

NCT00548678

Phase 1 Completed 30 enrolled Javelin Pharmaceuticals
RandomizedCrossoverOpen-labelTreatment

Summary

This study will assess platelet function and safety in healthy male volunteers following doses of intravenous diclofenac compared to oral diclofenac (Cataflam), intravenous ketorolac and oral aspirin.

Timeline

Start
2007-10
Primary completion
2007-11
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule Oral
Subject Diclofenac Other / unclassified Intravenous
Comparator Ketorolac Other / unclassified Intravenous

Indications

No indication recorded.